Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Insider Changes in Ownership
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 8-K Event Shareholder vote results
  4. DEFA14A Proxy Proxy Materials
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. ARS Other Annual Report to Security Holders
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 8-K Event Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 5 of 67 · 1,337 filings